Clinical Trials Sponsored by A. Vogel AG

Total 39 results

A. Vogel AG

Completed

Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats

Respiratory Tract Infection Viral | Tonsillopharyngitis

Bulgaria
A. Vogel AG

Completed

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

Urine Specimen Collection

Switzerland
A. Vogel AG

Completed

Clinical Trial for Assessment of Safety and Efficacy of a Echinacea/Sage Spray Compared to a Chlorhexidine/Lidocaine Spray in the Treatment of Acute Sore Throats

Pharyngitis

Switzerland
A. Vogel AG

Completed

Study of Echinaforce Junior Tablets in Children With Acute Colds

Respiratory Tract Diseases

Switzerland
A. Vogel AG

Terminated

Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating

Menopausal Hot Flushes

Switzerland
A. Vogel AG

Completed

Echinacea Safety Study

Infections

United Kingdom
A. Vogel AG

Completed

Echinacea Junior vs Vitamin C in Children 4-12 Years Old

Respiratory Tract Infection Viral

Switzerland
A. Vogel AG
University of London

Unknown

Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions

Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia

Switzerland
A. Vogel AG
University Children's Hospital, Zurich

Withdrawn

Echinaforce Junior Bioavailability Trial

Common Cold

Switzerland
A. Vogel AG
University of Newcastle Upon-Tyne

Enrolling by invitation

Mental Balance Study

Mental Health Wellness 1 | Work Related Stress

United Kingdom
University of Aberdeen
A. Vogel

Terminated

RIGHTWHEY - Responders In Gut HealTh Markers Using Fermented WHEY (RIGHTWHEY)

Healthy | Health, Subjective | Microbial Colonization

United Kingdom
University of Aberdeen
A. Vogel

Completed

Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults

Healthy

United Kingdom
A. Vogel AG
Cantonal Hospital of St. Gallen; Labormedizinisches Zentrum Dr. Risch

Completed

Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections

Respiratory Tract Infections

Switzerland
A. Vogel AG
Daacro GmbH & Co. KG, Max-Planck-Str. 22, 54296 Trier/Germany

Not yet recruiting

Sleep Well Observation Study

Sleep Disturbance

Germany
A. Vogel AG
Medical University of Graz; MediStat Ltd.; Biodome Clinical; Clinical Research...

Recruiting

Echinaforce COVID-19 Shedding Study

SARS-CoV2 Infection | COVID-19 Respiratory Infection

Bulgaria
KeyBioscience AG
Nordic Bioscience A/S

Completed

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
A. Vogel AG
CONVEX CRO; d.s.h. statistical services GmbH; MediStat Ltd.; Biodome Clinical; Bo... and other collaborators

Completed

Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections

Respiratory Tract Infections | Common Cold

Bulgaria
Texas A&M University
Institut Straumann AG

Recruiting

The Use of a Non-Incised Minimally Invasive Flap Procedure in Conjunction With Emdogain® MI Compared to Traditional SRCP

Periodontitis | Attachment Loss, Periodontal

United States
CellMed AG, a subsidiary of BTG plc.

Completed

First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of CM3.1-AC100

Healthy

Germany
CellMed AG, a subsidiary of BTG plc.

Completed

Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes

Type II Diabetes Mellitus

Germany
CellMed AG, a subsidiary of BTG plc.

Terminated

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Intracerebral Hemorrhage (ICH)

Germany
CellMed AG, a subsidiary of BTG plc.

Completed

Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers

Healthy

Germany
University of Michigan Rogel Cancer Center
Genzyme, a Sanofi Company

Completed

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome

United States
Mayo Clinic
Wyeth is now a wholly owned subsidiary of Pfizer; Roche Pharma AG; Genzyme, a...

Completed

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

Kidney Diseases

United States
University Hospital Freiburg
Roche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbH

Completed

Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation (Harmony)

Disorder Related to Renal Transplantation

Germany
University of Minnesota
Wyeth is now a wholly owned subsidiary of Pfizer; Roche Pharma AG; Genzyme, a...

Completed

Calcineurin Inhibitor Sparing After Kidney Transplantation (CNI-Sparing)

CNI Side Effects

United States
University of Michigan Rogel Cancer Center
Genzyme, a Sanofi Company; Otsuka Pharmaceutical Development & Commercialization...

Completed

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen (CloBu4)

Acute Myeloblastic Leukemia

United States, Canada
Instituto Oncológico Dr Rosell
Roche Pharma AG; Fundacion Clinic per a la Recerca Biomédica

Active, not recruiting

Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer (VENEZO-LUNG)

Extensive-stage Small Cell Lung Cancer

Spain
KeyBioscience AG
Eli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...

Terminated

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

Type II Diabetes Mellitus

Germany
University Hospital, Brest
Novartis; Roche Pharma AG; Ministry of Health, France; Genzyme, a Sanofi Company

Completed

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation (EVEROLD)

Renal Transplant

France
Centre Francois Baclesse
Roche Pharma AG; Hospira, now a wholly owned subsidiary of Pfizer; Vifor Pharma

Terminated

Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

Solid Cancer Metastatic Disease | Lymphoid Disease

France
Hvidovre University Hospital
Novo Nordisk A/S; Roche Pharma AG; Medtronic; The Danish Council for Strategic...

Completed

Study of the Effects of Carbohydrate Counting

Type 1 Diabetes

Denmark
QualiCCare
Novo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaborators

Completed

Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland

Diabetes Mellitus, Type 2 | Primary Care

Switzerland
Dent Neuroscience Research Center
Genentech, Inc., a subsidiary of F. Hoffman-La Roche AG; Monogram Biosciences...

Not yet recruiting

Serum Neurofilament Light in Multiple Sclerosis

Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis
Association Nationale pour les Traitements A Domicile...
GlaxoSmithKline; Roche Pharma AG; Baxter Healthcare Corporation; Vaincre la Mucoviscidose

Terminated

Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis

Cystic Fibrosis | Pseudomonas Aeruginosa | Pulmonary Exacerbation

France
SepNet - Critical Care Trials Group
Novo Nordisk A/S; German Federal Ministry of Education and Research; B. Braun... and other collaborators

Completed

Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)

Septic Shock | Severe Sepsis

Germany
Espen A. Haavardsholm
Oslo University Hospital; Pfizer; Roche Pharma AG; The Research Council of Norway; The Norwegian Rheumatism Association and other collaborators

Completed

Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial (ARCTIC)

Rheumatoid Arthritis

Norway
Oncoimmune, Inc., a subsidiary of Merck & Co.,...
National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio... and other collaborators

Completed

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

Leukemia | Hematopoietic Stem Cell Transplantation | Graft Versus Host Disease

United States
Fondation Francophone pour la Recherche sur le...
Eli Lilly and Company; Novo Nordisk A/S; Sanofi; Institut National de la Santé... and other collaborators

Recruiting

French National Cohort of People With Type 1 Diabetes (SFDT1)

Cardiovascular Diseases | Hypoglycemia | Diabetes Mellitus, Type 1 | Patient Participation

France

Clinical Trials Sponsored by A. Vogel AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations